ImmuCell Corporation (ICCC) News

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

PORTLAND, Maine, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the...

Form 8-K - Current report

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024

PORTLAND, Maine, Feb. 20, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the...

ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses

PORTLAND, Maine, Jan. 16, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the...

Form 8-K - Current report

Form 8-K - Current report

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024

PORTLAND, Maine, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the...

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024

PORTLAND, Maine, Nov. 13, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the...

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024

PORTLAND, Maine, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the...

Form 8-K - Current report

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024

PORTLAND, Maine, Oct. 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the...

Form 8-K - Current report